WVP
ATEX icon

Worth Venture Partners’s Anterix ATEX Stock Holding History

Worth Venture Partners’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,257
Closed -$95.1K – 103
2019
Q2 		$107K Sell
2,257
-106
-4% -$4.48K 0.06% 72
2019
Q1 		$83K Buy
2,363
+1,235
+109% +$48.5K 0.05% 74
2018
Q4 		$42K Buy
+1,128
New +$44.1K 0.03% 78

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCC
Bain Capital Credit Boston, Massachusetts $368M AUM 9.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Worth Venture Partners's ATEX Position: Q3 2019 in Review

Worth Venture Partners sold out of Anterix (ATEX) in Q3 2019, closing a stake of 2,257 shares — an estimated $95.1K sold.

Worth Venture Partners first reported a position in ATEX in Q4 2018 and held it in 3 quarters. The position peaked at $107K in Q2 2019. 75 funds tracked by Wall St. Rank hold ATEX as of Q3 2019.

  • Worth Venture Partners reported no remaining Anterix position as of Q3 2019 after selling out during the quarter.
  • Worth Venture Partners sold 2,257 Anterix shares in Q3 2019, an estimated $95.1K.
  • Worth Venture Partners first reported a position in Anterix in Q4 2018 and held it in 3 quarters.
  • Worth Venture Partners's Anterix position peaked at $107K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Anterix as of Q3 2019.

Based on Worth Venture Partners's 13F filing for Q3 2019, filed 12 Nov 2019.